ScellCare serves families with pregnant women. ScellCare is: Collection of Umbilical cord biosample, Processing to collect enriched stem cell component, Acquisition of progenitor cellular genomics information to generate predictive health signatures, cryopreserving stem cell units for intended applications. Collection of biosample is non-invasive, painless, and poses no risk to the donor. The predictive health signatures read donor specific profile as a report while the cryopreserved stem cell component (Hematopoietic and Mesenchymal stem cells) is worth to address 40 medical conditions with over 72 potential disease targets. Stem cell genomics analyzes the genome of stem cells to predict predisposition to both genetic and lifestyle related disorders.
ToothScell serves families with kids aged between 5 and 11 yr, patients undergoing Orthodontic corrections, healthy individuals with wisdom teeth. ToothScell collects about to fall milk teeth or teeth extracted during Orthodontic treatments or extracted wisdom teeth, processes stem cells from tooth harvested pulp, acquires stem cell-specific genomics data of the donor, who is the owner of the tooth collected, analyzes the sequence data integrating algorithms that generates predictive health signatures of the donor, cryopreserves the aliquot of sterile stem cell component in the biobank. The predictive health signature reads predisposition including oral cancers, heart ailments, and diabetes. ToothScell is to provide the donor an opportunity to elect any regenerative dentistry...
Bio Active Regenerative Tooth Implant (BARTI), a next generation dental implant application (patented) technology as a bridge with role in osseointegration and proprioception. BARTI is clinically proven to be biologically active, regenerative, reparative acting as a guided tool reinstating periodontal micro-physiology upon mounting. Some of the other key advantages associated with BARTI application are: no side effects, no rejection, decreased pain and inflammation.
Frozen acellular formulation constituting albumin, factor VIII, IgG, tested negative for Infectious diseases. Ready to ship with established logistics of maintaining integrity and stability
We have a growing repository of human stem cell (healthy donor) acquired de-identified genome sequence data sets. Big data driven drug development resources and methodologies have been evolving with ever expanding data enabling computational inference more relevant to identification of therapeutic targets and drugs for specific diseases and clinical scenarios. The same data sets can have a bigger role in public health programs analyzing population specific genetic susceptibility for the development of diseases, the presence of protective genetic factors, such as in resistance to infection etc to prevent the occurrence of diseases. Genome wide SNPs acquired and analyzed would provide unbiased estimates of genetic diversity as the backdrop for personalizing medicine